Authors: Guichard, S Montazeri, A Chatelut, E Hennebelle, I Bugat, R Canal, P

Citation: S. Guichard et al., Schedule-dependent activity of topotecan in OVCAR-3 ovarian carcinoma xenograft: Pharmacokinetic and pharmacodynamic evaluation, CLIN CANC R, 7(10), 2001, pp. 3222-3228

Authors: Guichard, S Arnould, S Hennebelle, I Bugat, R Canal, P

Citation: S. Guichard et al., Combination of oxaliplatin and irinotecan on human colon cancer cell lines: activity in vitro and in vivo, ANTI-CANC D, 12(9), 2001, pp. 741-751

Authors: Hennebelle, I Terret, C Chatelut, E Bugat, R Canal, P Guichard, S

Citation: I. Hennebelle et al., Characterization of CPT-11 converting carboxylesterase activity in colon tumor and normal tissues: comparison with p-nitra-phenylacetate converting carboxylesterase activity, ANTI-CANC D, 11(6), 2000, pp. 465-470

Authors: Guichard, S Terret, C Hennebelle, I Lochon, I Chevreau, P Fretigny, E Selves, J Chatelut, E Bugat, R Canal, P

Citation: S. Guichard et al., CPT-11 converting carboxylesterase and topoisomerase I activities in tumour and normal colon and liver tissues, BR J CANC, 80(3-4), 1999, pp. 364-370